- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01472042
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes (GATOR)
July 18, 2016 updated by: Banyan Biomarkers, Inc
A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
The purpose of this study is to study the biomarkers in subjects before and after sports-induced traumatic brain injury.
The assay will be studied in a sample population of subjects over the age of 18 participating in college sports.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Concussion or mild traumatic brain injury (mTBI) is a condition that affects hundreds of thousands of patients worldwide.
It is a biomechanically induced neurological injury, resulting in an alteration of mental status, such as confusion or amnesia, which may or may not involve a loss of consciousness.
Concussion affects about 1.6 million to 3.8 million athletes yearly, most commonly in contact sports such as American football and boxing.
Early clinical effects of concussion include but are not limited to behavioral changes, impairments of memory and attention, headache, unsteadiness, and rarely, catastrophic severe brain injury (sometimes described as second impact syndrome).
More recently, the consequences of repetitive mTBI from multiple concussions in a sports setting are becoming evident.
Repeated concussions have been associated with greater severity of symptoms, with longer recovery time, and chronically with earlier onset of age-related memory disturbances and dementia.
As a result and in contradistinction to the decades-earlier perception that these injuries were benign, sports medicine professionals are now increasingly being instructed to recognize and manage concussions as soon as they occur.
"Understanding the neurobiology of concussion will lead to development and validation of physiological biomarkers of this common injury."
These biomarkers (e.g., laboratory tests, imaging, electrophysiology) will then allow for improved detection, better functional assessment and evidence-based return to play recommendations.
Study Type
Observational
Enrollment (Actual)
265
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study will enroll athletes at the University of Florida, Gainesville.
Teams considered for inclusion in the study are men's football, women's lacrosse and women's soccer.
Description
Inclusion Criteria:
- The subject is a University of Florida student athlete on a team participating in the study
- The Subject is at least 18 years of age at screening (has had their 18th birthday)
- The Subject is willing to undergo the Informed Consent process prior to enrollment into this study.
- It is the Principal Investigator's opinion that based on the knowledge of the Subject that the Subject is an appropriate candidate for the study.
Exclusion Criteria:
- Participating in another clinical study that may affect the results of either study.
- Venipuncture not feasible (i.e. skin integrity compromised at the venipuncture sites, blood vessel calcification.
- Not available for the end of season follow-up visit.
- The Subject is otherwise determined by the Investigator to be medically unsuitable for participation in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Sports induced concussion
Exposure to sports induced concussion
|
Biomarkers to detect specific proteins.
|
Routine Athletic Exertion
Exposure to routine athletic exertion (non-concussion control)
|
Biomarkers to detect specific proteins.
|
Other Non-Penetrating Trauma to the Head
Exposure to other non-penetrating trauma to the head that is witnessed or self-reported
|
Biomarkers to detect specific proteins.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in levels of TBI biomarkers from baseline
Time Frame: 36 months
|
36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Association of TBI biomarker levels and the Post-Concussion Scale
Time Frame: 36 months
|
36 months
|
|
Association of TBI biomarker levels and the Standardized Assessment of Concussion
Time Frame: Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
|
Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
|
|
Association of TBI biomarker levels and the Balance Error Scoring System
Time Frame: 36 months
|
36 months
|
|
Safety
Time Frame: Throughout Participation in Study
|
The safety endpoints include the cumulative procedure-related adverse event-free survival, and cumulative unanticipated procedure-related adverse events.
The only potential risks to patients in this study are those that are normally related to routine blood collection.
|
Throughout Participation in Study
|
Assessment of pituitary status and determination of the presence of autoantibodies.
Time Frame: 36 months
|
36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jay Clugston, MD, University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (ACTUAL)
July 1, 2015
Study Completion (ACTUAL)
July 1, 2015
Study Registration Dates
First Submitted
September 7, 2011
First Submitted That Met QC Criteria
November 11, 2011
First Posted (ESTIMATE)
November 16, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
July 20, 2016
Last Update Submitted That Met QC Criteria
July 18, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ATO-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Brain Injury
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueNot yet recruitingTBI (Traumatic Brain Injury)France
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
Queen Mary University of LondonCompleted
-
First Affiliated Hospital Xi'an Jiaotong UniversityXijing Hospital; Second Affiliated Hospital of Wenzhou Medical University; Central... and other collaboratorsRecruitingMTBI - Mild Traumatic Brain Injury | Moderate Traumatic Brain InjuryChina
Clinical Trials on Banyan Biomarkers
-
Assistance Publique Hopitaux De MarseilleCompletedAmyloid Neuropathies | Transthyretin AmyloidosisFrance
-
Children's Hospital Medical Center, CincinnatiThe Leona M. and Harry B. Helmsley Charitable TrustActive, not recruiting
-
Istituto Clinico HumanitasIstituto Superiore di Sanità; Ospedale San Raffaele; University of Paris 5 -... and other collaboratorsUnknown
-
West China HospitalRecruitingBiomarkers | NeonateChina
-
Central Hospital, Nancy, FranceRecruiting
-
First Affiliated Hospital of Chongqing Medical...Unknown
-
Corporacion Parc TauliHospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital Arnau... and other collaboratorsUnknownPulmonary Disease, Chronic Obstructive | Exacerbation COPDSpain
-
Corporacion Parc TauliInstituto de Salud Carlos III; Consorcio Centro de Investigación Biomédica...Unknown
-
Far Eastern Memorial HospitalWithdrawnLower Urinary Tract SymptomsTaiwan
-
University of BaghdadNot yet recruiting